scispace - formally typeset
C

Conxi Lázaro

Researcher at Carlos III Health Institute

Publications -  273
Citations -  14817

Conxi Lázaro is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 60, co-authored 248 publications receiving 12617 citations. Previous affiliations of Conxi Lázaro include Dresden University of Technology & King's College London.

Papers
More filters
Journal ArticleDOI

Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

Kelly L. Bolton, +77 more
- 25 Jan 2012 - 
TL;DR: Among patients with invasive EOC, having a germline mutation in BRCA1 or BRC a2 was associated with improved 5-year overall survival and BRCa2 carriers had the best prognosis.
Journal ArticleDOI

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat, +132 more
TL;DR: Pathologic characteristics of BRCA1 and BRCa2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
Journal ArticleDOI

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch, +261 more
- 27 Mar 2013 - 
TL;DR: It is estimated that the breast cancer lifetime risks for the5% of BRCA1 carriers at lowest risk are 28%–50% compared to 81%–100% for the 5% at highest risk, and the ovarian cancer lifetime risk is 63% or higher, based on the known cancer risk-modifying loci.